{"id":4933,"date":"2026-11-16T15:20:52","date_gmt":"2026-11-16T14:20:52","guid":{"rendered":"https:\/\/ibsh.hu\/?page_id=4933"},"modified":"2026-11-16T16:17:25","modified_gmt":"2026-11-16T15:17:25","slug":"ginop-plus-2-1-5-26","status":"publish","type":"page","link":"https:\/\/ibsh.hu\/en\/ginop-plus-2-1-5-26\/","title":{"rendered":"GINOP Plus-2.1.5-26"},"content":{"rendered":"<div class=\"gb-container gb-container-9c977082\" id=\"hero\">\n<div class=\"gb-container gb-container-a15e61d9\">\n<p class=\"gb-headline gb-headline-6b0e2b1a gb-headline-text\"><strong><strong><strong><strong><strong><strong><strong><strong><strong>Life Sciences Catalyst Program<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/p>\n\n<div class=\"gb-headline gb-headline-115b2264 gb-headline-text custom-hr\"><\/div>\n\n<h1 class=\"gb-headline gb-headline-630cf83c gb-headline-text\">GINOP Plus-2.1.5-26<\/h1>\n\n<p class=\"gb-headline gb-headline-f68c5799 gb-headline-text\"><strong><strong>Up to HUF 3 Billion in Funding for Healthcare Research and Development Projects<\/strong><\/strong><\/p>\n\n<a class=\"gb-button gb-button-410966d9 gb-button-text\" href=\"#kapcsolat\"><strong>CHECK MY ELIGIBILITY<\/strong><\/a>\n<\/div>\n<\/div><div class=\"gb-container gb-container-d7cd5ef4\" id=\"ajanlat\">\n<div class=\"gb-container gb-container-40e28408\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-c1a293cc\">\n<div class=\"gb-grid-column gb-grid-column-38abc26c\"><div class=\"gb-container gb-container-38abc26c\">\n<h2 class=\"gb-headline gb-headline-086be1a8 gb-headline-text\"><strong><strong><strong><strong><strong><strong><strong>Programme Objective<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/h2>\n\n<div class=\"gb-headline gb-headline-fea66da1 gb-headline-text custom-hr\"><\/div>\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<div class=\"gb-container gb-container-6cb0c4cf\">\n<p class=\"wp-block-paragraph\">A new funding opportunity is becoming available for small and medium-sized enterprises (SMEs) operating in Hungary&#8217;s healthcare industry under the <strong>GINOP Plus-2.1.5-26 \u2013 Life Sciences Catalyst Program<\/strong>. With a total budget of HUF 15 billion, the programme supports the development of innovative medical devices and early-stage clinical trials of drug candidates. Eligible businesses can apply for <strong>non-repayable grants ranging from HUF 300 million to HUF 3 billion<\/strong>, with a project implementation period of up to 30 months.<\/p>\n\n<p class=\"wp-block-paragraph\">Applications can be submitted <strong>between 5 January and 2 March 2027<\/strong>. While the programme offers substantial funding opportunities, it also sets strict scientific, technological and research and development requirements. Companies considering an application should therefore begin their preparations well in advance.<\/p>\n<\/div>\n\n<div class=\"gb-container gb-container-8b4c71b8\">\n<h4 class=\"gb-headline gb-headline-1cd30c92\"><span class=\"gb-icon\"><svg aria-hidden=\"true\" role=\"img\" height=\"1em\" width=\"1em\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path fill=\"currentColor\" d=\"M400 480H48c-26.51 0-48-21.49-48-48V80c0-26.51 21.49-48 48-48h352c26.51 0 48 21.49 48 48v352c0 26.51-21.49 48-48 48zm-204.686-98.059l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.248-16.379-6.249-22.628 0L184 302.745l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.25 16.379 6.25 22.628.001z\"><\/path><\/svg><\/span><span class=\"gb-headline-text\"><strong><strong><strong><strong><strong><strong><strong>GINOP Plusz-2.1.5-26: HUF 15 Billion to Support Healthcare Innovation<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/span><\/h4>\n<\/div>\n\n<p class=\"wp-block-paragraph\">The <strong>GINOP Plus-2.1.5-26 funding programme<\/strong> aims to facilitate healthcare developments that demonstrate significant scientific and technological novelty while supporting the future commercialisation of research results.<\/p>\n\n<p class=\"wp-block-paragraph\">The programme primarily focuses on projects that address genuine unmet clinical needs and offer innovative solutions capable of improving diagnostic, preventive or therapeutic opportunities.<\/p>\n\n<p class=\"wp-block-paragraph\">The call supports two main development areas:<\/p>\n\n<ul class=\"wp-block-list\"><li><strong>Medical device development (Component A):<\/strong> Research and development of innovative medical devices based on non-biotechnological methods.<\/li>\n\n<li><strong>Drug development (Component B):<\/strong> Implementation of Phase I clinical trials of drug candidates, with particular emphasis on safety assessments associated with first-in-human administration.<\/li><\/ul>\n\n<p class=\"wp-block-paragraph\">Of the total HUF 15 billion funding allocation, <strong>HUF 10 billion is earmarked for projects implemented in Budapest<\/strong>, while the remaining <strong>HUF 5 billion is allocated to projects in Hungary&#8217;s less developed regions<\/strong>.<\/p>\n\n<div class=\"gb-container gb-container-d11584da\">\n<h4 class=\"gb-headline gb-headline-9e076935\"><span class=\"gb-icon\"><svg aria-hidden=\"true\" role=\"img\" height=\"1em\" width=\"1em\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path fill=\"currentColor\" d=\"M400 480H48c-26.51 0-48-21.49-48-48V80c0-26.51 21.49-48 48-48h352c26.51 0 48 21.49 48 48v352c0 26.51-21.49 48-48 48zm-204.686-98.059l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.248-16.379-6.249-22.628 0L184 302.745l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.25 16.379 6.25 22.628.001z\"><\/path><\/svg><\/span><span class=\"gb-headline-text\"><strong><strong><strong><strong><strong><strong><strong><strong><strong>Up to HUF 3 Billion in Non-Repayable Grants<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/span><\/h4>\n\n<p class=\"wp-block-paragraph\">Under GINOP Plus-2.1.5-26, eligible applicants can request funding ranging from HUF 300 million to HUF 3 billion.<\/p>\n\n<p class=\"wp-block-paragraph\">The main financing conditions are summarised below:<\/p>\n\n<div class=\"wp-block-getwid-table has-table-layout-auto has-border-collapse-separate\"><table><tbody><tr><td style=\"text-align:center;vertical-align:middle;background-color:#f5af19;color:var(--base-3);border-color:var(--contrast-3)\"><strong><strong><strong><strong><strong><strong>Funding parameter<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/td><td style=\"text-align:center;vertical-align:middle;background-color:#f5af19;color:var(--base-3);border-color:var(--contrast-3)\"><strong><strong><strong><strong><strong><strong>Key information<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/td><\/tr><tr><td style=\"text-align:center;vertical-align:middle;border-color:var(--contrast-3);background-color:#fff5de\"><strong><strong>Call reference<\/strong><\/strong><\/td><td style=\"text-align:center;vertical-align:middle;border-color:var(--contrast-3)\">GINOP Plus-2.1.5-26<\/td><\/tr><tr><td style=\"text-align:center;vertical-align:middle;border-color:var(--contrast-3);background-color:#fff5de\"><strong><strong>Programme<\/strong><\/strong><\/td><td style=\"text-align:center;vertical-align:middle;border-color:var(--contrast-3)\">Life Sciences Catalyst Program<\/td><\/tr><tr><td style=\"border-color:#000;background-color:#fff5de;text-align:center;vertical-align:middle\"><strong>Total programme budget<\/strong><\/td><td style=\"border-color:#000;text-align:center;vertical-align:middle\">HUF 15 billion<\/td><\/tr><tr><td style=\"border-color:#000;background-color:#fff5de;text-align:center;vertical-align:middle\"><strong>Available grant amount<\/strong><\/td><td style=\"border-color:#000;text-align:center;vertical-align:middle\">HUF 300 million \u2013 HUF 3 billion<\/td><\/tr><tr><td style=\"border-color:#000;background-color:#fff5de;text-align:center;vertical-align:middle\"><strong>Form of support<\/strong><\/td><td style=\"border-color:#000;text-align:center;vertical-align:middle\">Non-repayable grant<\/td><\/tr><tr><td style=\"border-color:#000;background-color:#fff5de;text-align:center;vertical-align:middle\"><strong>Advance payment<\/strong><\/td><td style=\"border-color:#000;text-align:center;vertical-align:middle\">Up to 30%, maximum HUF 900 million<\/td><\/tr><tr><td style=\"border-color:#000;background-color:#fff5de;text-align:center;vertical-align:middle\"><strong>Project implementation<\/strong><\/td><td style=\"border-color:#000;text-align:center;vertical-align:middle\">Maximum 30 months<\/td><\/tr><tr><td style=\"border-color:#000;background-color:#fff5de;text-align:center;vertical-align:middle\"><strong>Project location<\/strong><\/td><td style=\"border-color:#000;text-align:center;vertical-align:middle\">Throughout Hungary<\/td><\/tr><tr><td style=\"border-color:#000;background-color:#fff5de;text-align:center;vertical-align:middle\"><strong>Application period<\/strong><\/td><td style=\"border-color:#000;text-align:center;vertical-align:middle\">5 January \u2013 2 March 2027<\/td><\/tr><\/tbody><\/table><\/div>\n\n<p class=\"wp-block-paragraph\">The applicable aid intensity depends on several factors, particularly the size of the applicant company, the type of research and development activity and the relevant State aid regulations.<\/p>\n\n<p class=\"wp-block-paragraph\">Applicants must provide their own financial contribution to the project. Under the applicable R&amp;D aid conditions, <strong>industrial research requires a minimum own contribution of 20%, while experimental development requires at least 40%<\/strong>.<\/p>\n\n<p class=\"wp-block-paragraph\">An advance payment of up to 30% of the awarded grant may also be requested, subject to a maximum limit of HUF 900 million.<\/p>\n<\/div>\n\n<div class=\"gb-container gb-container-89aaf432\">\n<h4 class=\"gb-headline gb-headline-67ab70fa\"><span class=\"gb-icon\"><svg aria-hidden=\"true\" role=\"img\" height=\"1em\" width=\"1em\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path fill=\"currentColor\" d=\"M400 480H48c-26.51 0-48-21.49-48-48V80c0-26.51 21.49-48 48-48h352c26.51 0 48 21.49 48 48v352c0 26.51-21.49 48-48 48zm-204.686-98.059l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.248-16.379-6.249-22.628 0L184 302.745l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.25 16.379 6.25 22.628.001z\"><\/path><\/svg><\/span><span class=\"gb-headline-text\"><strong><strong><strong><strong><strong><strong><strong><strong><strong><strong>What Types of Projects Are Eligible Under GINOP Plus-2.1.5-26?<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/span><\/h4>\n\n<h5 class=\"wp-block-heading\"><strong><strong>Medical Device Development \u2013 Component A<\/strong><\/strong><\/h5>\n\n<p class=\"wp-block-paragraph\">Component A supports the development of innovative medical devices based on non-biotechnological methods that address significant clinical needs.<\/p>\n\n<p class=\"wp-block-paragraph\">Funding may be available for the development of medical technologies intended for diagnostic, preventive, therapeutic and other healthcare applications.<\/p>\n\n<p class=\"wp-block-paragraph\">The programme exclusively supports the development of devices classified within <strong>Classes IIa, IIb or III under the Medical Device Regulation (MDR)<\/strong>, or <strong>Classes B, C or D under the In Vitro Diagnostic Medical Devices Regulation (IVDR)<\/strong>.<\/p>\n\n<p class=\"wp-block-paragraph\">Eligible activities include:<\/p>\n\n<ul class=\"wp-block-list\"><li>Experimental development.<\/li>\n\n<li>Industrial (applied) research.<\/li>\n\n<li>Obtaining the relevant medical device certification.<\/li>\n\n<li>Activities supporting the implementation of the research and development project.<\/li><\/ul>\n\n<p class=\"wp-block-paragraph\">The development must start at a minimum of <strong>Technology Readiness Level (TRL) 3, with activities at this level already commenced<\/strong>, and reach at least <strong>completed TRL 7<\/strong> by the end of the project.<\/p>\n\n<p class=\"wp-block-paragraph\">An additional important requirement for Component A is the possession of an R&amp;D qualification issued by the Hungarian National Research, Development and Innovation Office (NRDI Office).<\/p>\n\n<h5 class=\"wp-block-heading\"><strong><strong><strong>Drug Development and Phase I Clinical Trials \u2013 Component B<\/strong><\/strong><\/strong><\/h5>\n\n<p class=\"wp-block-paragraph\">Component B supports the early clinical development of drug candidates, providing funding for the implementation of Phase I clinical trials.<\/p>\n\n<p class=\"wp-block-paragraph\">The objective is to enable drug development projects to progress through the safety assessments associated with first-in-human administration, establishing the foundation for subsequent clinical development stages.<\/p>\n\n<p class=\"wp-block-paragraph\">Eligible activities include:<\/p>\n\n<ul class=\"wp-block-list\"><li>Experimental development.<\/li>\n\n<li>Conducting clinical trial authorisation procedures.<\/li>\n\n<li>Related activities supporting research and development.<\/li><\/ul>\n\n<p class=\"wp-block-paragraph\">Under Component B, projects must start at a minimum of <strong>completed TRL 5<\/strong> and achieve at least <strong>completed TRL 6<\/strong> by the end of implementation.<\/p>\n\n<p class=\"wp-block-paragraph\">One of the key requirements for project completion is the preparation of a Phase I clinical study report necessary to support the initiation of Phase II clinical trials.<\/p>\n<\/div>\n\n<div class=\"gb-container gb-container-e0385853\">\n<h4 class=\"gb-headline gb-headline-89ad7e90\"><span class=\"gb-icon\"><svg aria-hidden=\"true\" role=\"img\" height=\"1em\" width=\"1em\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path fill=\"currentColor\" d=\"M400 480H48c-26.51 0-48-21.49-48-48V80c0-26.51 21.49-48 48-48h352c26.51 0 48 21.49 48 48v352c0 26.51-21.49 48-48 48zm-204.686-98.059l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.248-16.379-6.249-22.628 0L184 302.745l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.25 16.379 6.25 22.628.001z\"><\/path><\/svg><\/span><span class=\"gb-headline-text\"><strong><strong><strong><strong><strong><strong><strong><strong><strong><strong><strong>Who Can Apply for GINOP Plus-2.1.5-26 Funding?<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/span><\/h4>\n\n<p class=\"wp-block-paragraph\">The programme is primarily available to small and medium-sized enterprises operating in the healthcare industry.<\/p>\n\n<p class=\"wp-block-paragraph\">Companies applying independently must meet several eligibility requirements, including:<\/p>\n\n<ul class=\"wp-block-list\"><li>Having at least two completed, full financial years.<\/li>\n\n<li>Employing an average statistical headcount of at least six employees during the most recently completed full financial year.<\/li>\n\n<li>Having a registered office in Hungary or an eligible Hungarian branch office.<\/li>\n\n<li>Maintaining double-entry bookkeeping.<\/li>\n\n<li>Having at least one of the healthcare-related TE\u00c1OR business activities specified in the call registered before the relevant deadline.<\/li><\/ul>\n\n<p class=\"wp-block-paragraph\">Eligible business activities include pharmaceutical manufacturing, research and experimental development in natural sciences and engineering, medical device manufacturing, and certain diagnostic imaging and medical laboratory services.<\/p>\n\n<p class=\"wp-block-paragraph\"><strong>Consortium applications are also permitted<\/strong>, with a maximum of three participating organisations. In such cases, the consortium leader must be an eligible healthcare industry SME with an average statistical headcount of at least three employees in its most recently completed full financial year.<\/p>\n\n<p class=\"wp-block-paragraph\">Other enterprises, research institutions and eligible research and knowledge-dissemination organisations may participate as consortium partners.<\/p>\n<\/div>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-6a37c993\"><div class=\"gb-container gb-container-6a37c993\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"657\" height=\"382\" src=\"https:\/\/ibsh.hu\/wp-content\/uploads\/2026\/11\/GINOP-Plusz-2.1.5-26-atricle.png\" alt=\"\" class=\"wp-image-4931\" srcset=\"https:\/\/ibsh.hu\/wp-content\/uploads\/2026\/11\/GINOP-Plusz-2.1.5-26-atricle.png 657w, https:\/\/ibsh.hu\/wp-content\/uploads\/2026\/11\/GINOP-Plusz-2.1.5-26-atricle-300x174.png 300w, https:\/\/ibsh.hu\/wp-content\/uploads\/2026\/11\/GINOP-Plusz-2.1.5-26-atricle-18x10.png 18w\" sizes=\"auto, (max-width: 657px) 100vw, 657px\" \/><\/figure>\n\n<div class=\"gb-container gb-container-303f0010\">\n<p class=\"wp-block-paragraph\"><\/p>\n\n<h4 class=\"gb-headline gb-headline-781f3a65\"><span class=\"gb-icon\"><svg aria-hidden=\"true\" role=\"img\" height=\"1em\" width=\"1em\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path fill=\"currentColor\" d=\"M400 480H48c-26.51 0-48-21.49-48-48V80c0-26.51 21.49-48 48-48h352c26.51 0 48 21.49 48 48v352c0 26.51-21.49 48-48 48zm-204.686-98.059l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.248-16.379-6.249-22.628 0L184 302.745l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.25 16.379 6.25 22.628.001z\"><\/path><\/svg><\/span><span class=\"gb-headline-text\"><strong><strong><strong><strong><strong><strong><strong><strong><strong><strong><strong><strong>Strict Scientific and Research Staffing Requirements<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/span><\/h4>\n<\/div>\n\n<p class=\"wp-block-paragraph\">One of the distinguishing features of GINOP Plus-2.1.5-26 is that an innovative development concept alone is not sufficient to secure funding. Applicants must demonstrate the scientific and technological justification of their project, the relevance of the clinical need being addressed and the potential for commercial exploitation.<\/p>\n\n<p class=\"wp-block-paragraph\">The call also establishes specific requirements regarding research personnel.<\/p>\n\n<p class=\"wp-block-paragraph\">Throughout project implementation, beneficiaries must employ at least one <strong>researcher or developer holding a PhD degree<\/strong> relevant to the project&#8217;s field of expertise, working a minimum of 20 hours per week.<\/p>\n\n<p class=\"wp-block-paragraph\">In addition, the project must employ at least one female researcher, developer, technician or research support staff member for a minimum of six months during the implementation period, also working at least 20 hours per week.<\/p>\n\n<p class=\"wp-block-paragraph\">Another key requirement is that beneficiaries must obtain accredited certification under the <strong>ISO 56001:2024 Innovation Management System<\/strong> standard by the physical completion of the project.<\/p>\n\n<p class=\"wp-block-paragraph\">Intellectual property obligations may also apply to the developments. Where applicants do not already hold the relevant industrial property protection or have an application pending at the time of submission, they must fulfil the applicable intellectual property requirements within 24 months following project completion.<\/p>\n\n<h4 class=\"gb-headline gb-headline-c7dc059b\"><span class=\"gb-icon\"><svg aria-hidden=\"true\" role=\"img\" height=\"1em\" width=\"1em\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path fill=\"currentColor\" d=\"M400 480H48c-26.51 0-48-21.49-48-48V80c0-26.51 21.49-48 48-48h352c26.51 0 48 21.49 48 48v352c0 26.51-21.49 48-48 48zm-204.686-98.059l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.248-16.379-6.249-22.628 0L184 302.745l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.25 16.379 6.25 22.628.001z\"><\/path><\/svg><\/span><span class=\"gb-headline-text\"><strong><strong><strong><strong><strong><strong><strong><strong><strong><strong><strong><strong><strong>When Can GINOP Plusz-2.1.5-26 Applications Be Submitted?<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/span><\/h4>\n\n<p class=\"wp-block-paragraph\">The application submission period is:<\/p>\n\n<p class=\"wp-block-paragraph\"><strong><strong><strong>5 January 2027, 9:00 AM \u2013 2 March 2027, 10:00 AM<\/strong><\/strong><\/strong><\/p>\n\n<p class=\"wp-block-paragraph\">Applications must be submitted electronically through the EPTK application system available on the official Hungarian funding portal, <a href=\"https:\/\/www.palyazat.gov.hu\" target=\"_blank\" rel=\"noopener\">palyazat.gov.hu<\/a>.<\/p>\n\n<p class=\"wp-block-paragraph\">Companies are advised to begin preparing their applications well in advance, as the process may require substantial scientific, technical and financial documentation.<\/p>\n\n<p class=\"wp-block-paragraph\">Particular attention should be paid to obtaining the required NRDI Office R&amp;D qualification under Component A, substantiating the project&#8217;s Technology Readiness Levels, demonstrating clinical needs and commercial potential, and planning the necessary research personnel capacity.<\/p>\n\n<div class=\"gb-container gb-container-9b3d21a9\">\n<h4 class=\"gb-headline gb-headline-ecd090bb\"><span class=\"gb-icon\"><svg aria-hidden=\"true\" role=\"img\" height=\"1em\" width=\"1em\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path fill=\"currentColor\" d=\"M400 480H48c-26.51 0-48-21.49-48-48V80c0-26.51 21.49-48 48-48h352c26.51 0 48 21.49 48 48v352c0 26.51-21.49 48-48 48zm-204.686-98.059l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.248-16.379-6.249-22.628 0L184 302.745l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.25 16.379 6.25 22.628.001z\"><\/path><\/svg><\/span><span class=\"gb-headline-text\"><strong><strong><strong><strong><strong><strong><strong><strong><strong><strong><strong>Why Companies Should Start Preparing for GINOP Plus-2.1.5-26 Now<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/span><\/h4>\n<\/div>\n\n<p class=\"wp-block-paragraph\">The <strong>GINOP Plus-2.1.5-26 \u2013 Life Sciences Catalyst Program<\/strong> represents a significant funding opportunity for healthcare companies planning to develop innovative medical devices or conduct early-stage clinical trials of drug candidates.<\/p>\n\n<p class=\"wp-block-paragraph\">With <strong>non-repayable grants of up to HUF 3 billion<\/strong>, the programme could help businesses implement large-scale research and development projects with substantial scientific and technological added value.<\/p>\n\n<p class=\"wp-block-paragraph\">However, the funding scheme includes complex eligibility, R&amp;D, employment and certification requirements. A thorough preliminary assessment of the proposed project and a detailed review of the application conditions are therefore particularly important.<\/p>\n\n<p class=\"wp-block-paragraph\"><strong>Is your company planning a medical device development project or an early-stage pharmaceutical research programme?<\/strong> Contact our expert team to assess your project&#8217;s preliminary eligibility, explore the available funding opportunities and identify the key steps required for successful application preparation.<\/p>\n\n<p class=\"wp-block-paragraph\"><em>Important: This information is based on the provided GINOP Plusz-2.1.5-26 Call for Proposals. The programme conditions may be amended. According to the call, the relevant European Union funding was blocked at the time of publication, meaning that applications may be placed on a reserve list. The official call documentation in force at the time of application submission shall always prevail.<\/em><\/p>\n\n<div class=\"gb-container gb-container-25280c8e\">\n<a class=\"gb-button gb-button-7ac0286b gb-button-text\" href=\"#kapcsolat\">Felveszem a kapcsolatot<\/a>\n<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div><div class=\"gb-container gb-container-7418a8d5\" id=\"idovonal\">\n<h3 class=\"gb-headline gb-headline-ef84e31f gb-headline-text\">\u00dczleti siker minden m\u00e9retben<\/h3>\n\n<h2 class=\"gb-headline gb-headline-bbdc7848 gb-headline-text\">Maximaliz\u00e1lja p\u00e1ly\u00e1zati eredm\u00e9nyeit<br>az ibsh seg\u00edts\u00e9g\u00e9vel<\/h2>\n\n<div class=\"gb-container gb-container-c595fc3c\">\n<div class=\"gb-container gb-container-274f226c\">\n<div class=\"gb-container gb-container-0c97f6b2\">\n<h6 class=\"gb-headline gb-headline-f6f59a91 gb-headline-text\">0<\/h6>\n<\/div>\n\n<p class=\"gb-headline gb-headline-39b92bed gb-headline-text\">D\u00edjmentes konzult\u00e1ci\u00f3 a t\u00e1mogat\u00e1si lehet\u0151s\u00e9gek kapcs\u00e1n<\/p>\n<\/div>\n\n<div class=\"gb-container gb-container-09e07825\">\n<div class=\"gb-container gb-container-810c0079\"><\/div>\n\n<p class=\"gb-headline gb-headline-0d2c96f1 gb-headline-text\">ibsh egy\u00fcttm\u0171k\u00f6d\u00e9s<\/p>\n<\/div>\n\n<div class=\"gb-container gb-container-c5f18c9e\">\n<div class=\"gb-container gb-container-08a74d07\">\n<h6 class=\"gb-headline gb-headline-31536d3b gb-headline-text\">1<\/h6>\n<\/div>\n\n<p class=\"gb-headline gb-headline-372bd6fb gb-headline-text\">V\u00e1llalat \u00e1llami t\u00e1mogat\u00e1si szempont\u00fa \u00e1tvil\u00e1g\u00edt\u00e1sa &amp; dedik\u00e1lt ibsh kontakt kijel\u00f6l\u00e9se<\/p>\n<\/div>\n\n<div class=\"gb-container gb-container-44c27fb6\">\n<div class=\"gb-container gb-container-9c58371d\">\n<h6 class=\"gb-headline gb-headline-c8124625 gb-headline-text\">2<\/h6>\n<\/div>\n\n<p class=\"gb-headline gb-headline-c504201c gb-headline-text\">T\u00e1mogathat\u00f3 projekt kialak\u00edt\u00e1sa, t\u00e1mogat\u00e1s ig\u00e9nyl\u00e9se<\/p>\n<\/div>\n\n<div class=\"gb-container gb-container-e2efbd6e\">\n<div class=\"gb-container gb-container-29658220\">\n<h6 class=\"gb-headline gb-headline-4cdb89b5 gb-headline-text\">3<\/h6>\n<\/div>\n\n<p class=\"gb-headline gb-headline-db2d34d2 gb-headline-text\">Kapcsolattart\u00e1s a kezel\u0151 szervvel, t\u00e1mogat\u00f3val<\/p>\n<\/div>\n\n<div class=\"gb-container gb-container-27827a44\">\n<div class=\"gb-container gb-container-96019a71\">\n<h6 class=\"gb-headline gb-headline-7d5aceed gb-headline-text\">4<\/h6>\n<\/div>\n\n<p class=\"gb-headline gb-headline-fc044485 gb-headline-text\">Elsz\u00e1mol\u00e1s \u00e9s besz\u00e1mol\u00f3k elk\u00e9sz\u00edt\u00e9se<\/p>\n<\/div>\n<\/div>\n<\/div><div class=\"gb-container gb-container-1171e486\" id=\"egyediseg\">\n<div class=\"gb-container gb-container-c0cb8e4a\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-7fd72f7b\">\n<div class=\"gb-grid-column gb-grid-column-d0696f8a\"><div class=\"gb-container gb-container-d0696f8a\">\n<figure class=\"gb-block-image gb-block-image-b401d651\"><img loading=\"lazy\" decoding=\"async\" width=\"1921\" height=\"1080\" class=\"gb-image gb-image-b401d651\" src=\"https:\/\/ibsh.hu\/wp-content\/uploads\/2024\/01\/egyedi.jpg\" alt=\"\" title=\"egyedi\" srcset=\"https:\/\/ibsh.hu\/wp-content\/uploads\/2024\/01\/egyedi.jpg 1921w, https:\/\/ibsh.hu\/wp-content\/uploads\/2024\/01\/egyedi-300x169.jpg 300w, https:\/\/ibsh.hu\/wp-content\/uploads\/2024\/01\/egyedi-1024x576.jpg 1024w, https:\/\/ibsh.hu\/wp-content\/uploads\/2024\/01\/egyedi-768x432.jpg 768w, https:\/\/ibsh.hu\/wp-content\/uploads\/2024\/01\/egyedi-1536x864.jpg 1536w, https:\/\/ibsh.hu\/wp-content\/uploads\/2024\/01\/egyedi-18x10.jpg 18w\" sizes=\"auto, (max-width: 1921px) 100vw, 1921px\" \/><\/figure>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-79c5bc2b\"><div class=\"gb-container gb-container-79c5bc2b\">\n<h2 class=\"gb-headline gb-headline-c7c8452c gb-headline-text\">Az ibsh egyedis\u00e9ge<\/h2>\n\n<div class=\"gb-headline gb-headline-0bcf1ddb gb-headline-text custom-hr\"><\/div>\n\n<p class=\"gb-headline gb-headline-cb8e9425\"><span class=\"gb-icon\"><svg aria-hidden=\"true\" role=\"img\" height=\"1em\" width=\"1em\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path fill=\"currentColor\" d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg><\/span><span class=\"gb-headline-text\">A piacon egyed\u00fcl\u00e1ll\u00f3, t\u00e1mogat\u00f3i oldalon szerzett tapasztalat<\/span><\/p>\n\n<p class=\"gb-headline gb-headline-19675703\"><span class=\"gb-icon\"><svg aria-hidden=\"true\" role=\"img\" height=\"1em\" width=\"1em\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path fill=\"currentColor\" d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg><\/span><span class=\"gb-headline-text\">Strat\u00e9giai el\u0151nnyel b\u00edr\u00f3 stabil szakmai kapcsolatok<\/span><\/p>\n\n<p class=\"gb-headline gb-headline-e34204c7\"><span class=\"gb-icon\"><svg aria-hidden=\"true\" role=\"img\" height=\"1em\" width=\"1em\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path fill=\"currentColor\" d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg><\/span><span class=\"gb-headline-text\">Szakmai felel\u0151ss\u00e9gv\u00e1llal\u00e1s, hossz\u00fat\u00e1v\u00fa partners\u00e9g kialak\u00edt\u00e1sa<\/span><\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div><div class=\"gb-container gb-container-2769f5e5\" id=\"kapcsolat\">\n<div class=\"gb-container gb-container-a48069ba\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-e514b358\">\n<div class=\"gb-grid-column gb-grid-column-c8ded54e\"><div class=\"gb-container gb-container-c8ded54e\">\n<h2 class=\"gb-headline gb-headline-5c00694a gb-headline-text\">tal\u00e1ljuk meg k\u00f6z\u00f6sen a c\u00e9g\u00e9nek a legjobb megold\u00e1st<\/h2>\n\n<div class=\"gb-headline gb-headline-cf91241a gb-headline-text custom-hr\"><\/div>\n\n<p class=\"gb-headline gb-headline-ce16deb9 gb-headline-text\">K\u00e9szen \u00e1ll, hogy kihaszn\u00e1lja az \u00e1llami t\u00e1mogat\u00e1sok \u00e9s p\u00e1ly\u00e1zatok ny\u00fajtotta lehet\u0151s\u00e9geket? T\u00f6ltse ki \u0171rlapunkat, \u00e9s l\u00e9pjen kapcsolatba szak\u00e9rt\u0151inkkel a r\u00e9szletek\u00e9rt!<\/p>\n\n<script>\nvar gform;gform||(document.addEventListener(\"gform_main_scripts_loaded\",function(){gform.scriptsLoaded=!0}),document.addEventListener(\"gform\/theme\/scripts_loaded\",function(){gform.themeScriptsLoaded=!0}),window.addEventListener(\"DOMContentLoaded\",function(){gform.domLoaded=!0}),gform={domLoaded:!1,scriptsLoaded:!1,themeScriptsLoaded:!1,isFormEditor:()=>\"function\"==typeof InitializeEditor,callIfLoaded:function(o){return!(!gform.domLoaded||!gform.scriptsLoaded||!gform.themeScriptsLoaded&&!gform.isFormEditor()||(gform.isFormEditor()&&console.warn(\"The use of gform.initializeOnLoaded() is deprecated in the form editor context and will be removed in Gravity Forms 3.1.\"),o(),0))},initializeOnLoaded:function(o){gform.callIfLoaded(o)||(document.addEventListener(\"gform_main_scripts_loaded\",()=>{gform.scriptsLoaded=!0,gform.callIfLoaded(o)}),document.addEventListener(\"gform\/theme\/scripts_loaded\",()=>{gform.themeScriptsLoaded=!0,gform.callIfLoaded(o)}),window.addEventListener(\"DOMContentLoaded\",()=>{gform.domLoaded=!0,gform.callIfLoaded(o)}))},hooks:{action:{},filter:{}},addAction:function(o,r,e,t){gform.addHook(\"action\",o,r,e,t)},addFilter:function(o,r,e,t){gform.addHook(\"filter\",o,r,e,t)},doAction:function(o){gform.doHook(\"action\",o,arguments)},applyFilters:function(o){return gform.doHook(\"filter\",o,arguments)},removeAction:function(o,r){gform.removeHook(\"action\",o,r)},removeFilter:function(o,r,e){gform.removeHook(\"filter\",o,r,e)},addHook:function(o,r,e,t,n){null==gform.hooks[o][r]&&(gform.hooks[o][r]=[]);var d=gform.hooks[o][r];null==n&&(n=r+\"_\"+d.length),gform.hooks[o][r].push({tag:n,callable:e,priority:t=null==t?10:t})},doHook:function(r,o,e){var t;if(e=Array.prototype.slice.call(e,1),null!=gform.hooks[r][o]&&((o=gform.hooks[r][o]).sort(function(o,r){return o.priority-r.priority}),o.forEach(function(o){\"function\"!=typeof(t=o.callable)&&(t=window[t]),\"action\"==r?t.apply(null,e):e[0]=t.apply(null,e)})),\"filter\"==r)return e[0]},removeHook:function(o,r,t,n){var e;null!=gform.hooks[o][r]&&(e=(e=gform.hooks[o][r]).filter(function(o,r,e){return!!(null!=n&&n!=o.tag||null!=t&&t!=o.priority)}),gform.hooks[o][r]=e)}});\n<\/script>\n\n                <div class='gf_browser_gecko gform_wrapper gravity-theme gform-theme--no-framework' data-form-theme='gravity-theme' data-form-index='0' id='gform_wrapper_1' ><div id='gf_1' class='gform_anchor' tabindex='-1'><\/div>\n                        <div class='gform_heading'>\n\t\t\t\t\t\t\t<p class='gform_required_legend'>&quot;<span class=\"gfield_required gfield_required_asterisk\">*<\/span>&quot; indicates required fields<\/p>\n                        <\/div><form method='post' enctype='multipart\/form-data' target='gform_ajax_frame_1' id='gform_1'  action='\/en\/wp-json\/wp\/v2\/pages\/4933#gf_1' data-formid='1' novalidate>\n                        <div class='gform-body gform_body'><div id='gform_fields_1' class='gform_fields top_label form_sublabel_below description_below validation_below' data-column-layout='fill'><div id=\"field_1_1\" class=\"gfield gfield--type-text gfield--input-type-text gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\" data-group-id=\"e38ff846\" data-field-span=\"12\"><label id='gfield_label_1_1' class='gfield_label gform-field-label' for='input_1_1'><span class='gform-field-label__text'>N\u00e9v<\/span><span class=\"gfield_required\"><span class=\"gfield_required gfield_required_asterisk\">*<\/span><\/span><\/label><div class='ginput_container ginput_container_text'><input name='input_1' id='input_1_1' type='text' value='' class='large'    placeholder='Az \u00d6n neve' aria-required=\"true\" aria-invalid=\"false\"   \/><\/div><\/div><div id=\"field_1_4\" class=\"gfield gfield--type-email gfield--input-type-email gfield--width-seven-twelfths gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\" data-group-id=\"9e0ef150\" data-field-span=\"7\"><label id='gfield_label_1_4' class='gfield_label gform-field-label' for='input_1_4'><span class='gform-field-label__text'>E-mail c\u00edm<\/span><span class=\"gfield_required\"><span class=\"gfield_required gfield_required_asterisk\">*<\/span><\/span><\/label><div class='ginput_container ginput_container_email'>\n                            <input name='input_4' id='input_1_4' type='email' value='' class='large'   placeholder='Az \u00d6n e-mail c\u00edme' aria-required=\"true\" aria-invalid=\"false\"  \/>\n                        <\/div><\/div><div id=\"field_1_8\" class=\"gfield gfield--type-phone gfield--input-type-phone gfield--phone-format-international gfield--width-five-twelfths gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\" data-group-id=\"9e0ef150\" data-field-span=\"5\"><label id='gfield_label_1_8' class='gfield_label gform-field-label' for='input_1_8'><span class='gform-field-label__text'>Telefonsz\u00e1m<\/span><span class=\"gfield_required\"><span class=\"gfield_required gfield_required_asterisk\">*<\/span><\/span><\/label><div class='ginput_container ginput_container_phone'><input name='input_8' id='input_1_8' type='tel' value='' class='large'  placeholder='Az \u00d6n telefonsz\u00e1ma' aria-required=\"true\" aria-invalid=\"false\"    \/><\/div><\/div><div id=\"field_1_5\" class=\"gfield gfield--type-textarea gfield--input-type-textarea gfield--width-full gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\" data-group-id=\"e51f5e5f\" data-field-span=\"12\"><label id='gfield_label_1_5' class='gfield_label gform-field-label' for='input_1_5'><span class='gform-field-label__text'>\u00dczenet<\/span><span class=\"gfield_required\"><span class=\"gfield_required gfield_required_asterisk\">*<\/span><\/span><\/label><div class='ginput_container ginput_container_textarea'><textarea name='input_5' id='input_1_5' class='textarea small'    placeholder='K\u00e9rj\u00fck, ide \u00edrja \u00fczenet\u00e9t' aria-required=\"true\" aria-invalid=\"false\"   rows='10' cols='50'><\/textarea><\/div><\/div><div id=\"field_1_7\" class=\"gfield gfield--type-hidden gfield--input-type-hidden gfield--width-full gform_hidden field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\" data-group-id=\"ae850885\" data-field-span=\"12\"><div class='ginput_container ginput_container_text'><input name='input_7' id='input_1_7' type='hidden' class='gform_hidden'  aria-invalid=\"false\" value='' \/><\/div><\/div><fieldset id=\"field_1_6\" class=\"gfield gfield--type-consent gfield--type-choice gfield--input-type-consent gfield--width-full gfield_contains_required field_sublabel_below gfield--no-description field_description_below hidden_label field_validation_below gfield_visibility_visible gfield--choice-align-vertical\" data-group-id=\"8daec9e1\" data-field-span=\"12\"><legend id='gfield_label_1_6' class='gfield_label gform-field-label gfield_label_before_complex' ><span class='gform-field-label__text'>Adatv\u00e9delem<\/span><span class=\"gfield_required\"><span class=\"gfield_required gfield_required_asterisk\">*<\/span><\/span><\/legend><div class='ginput_container ginput_container_consent'><input name='input_6.1' id='input_1_6_1' type='checkbox' value='1'   aria-labelledby=\"input_1_6_1_label gfield_label_1_6\" aria-required=\"true\" aria-invalid=\"false\"   \/> <label id='input_1_6_1_label' class=\"gform-field-label gform-field-label--type-inline gfield_consent_label\" for='input_1_6_1' ><span class='gform-field-label__text'>Elfogadom az <a href=\"https:\/\/ibsh.hu\/adatkezelesi-tajekoztato\/\" target=\"_blank\">adatv\u00e9delmi szab\u00e1lyzatot.<\/a><\/span><span class=\"gfield_required gfield_required_asterisk\">*<\/span><\/label><input type='hidden' name='input_6.2' value='Elfogadom az &lt;a href=&quot;https:\/\/ibsh.hu\/adatkezelesi-tajekoztato\/&quot; target=&quot;_blank&quot;&gt;adatv\u00e9delmi szab\u00e1lyzatot.&lt;\/a&gt;' class='gform_hidden' \/><input type='hidden' name='input_6.3' value='1' class='gform_hidden' \/><\/div><\/fieldset><\/div><\/div>\n        <div class='gform-footer gform_footer top_label'> <button type='submit' id='gform_submit_button_1' class='gform_button button' onclick='gform.submission.handleButtonClick(this);' data-submission-type='submit' >\u00dczenet k\u00fcld\u00e9se<\/button> <input type='hidden' name='gform_ajax' value='form_id=1&amp;title=&amp;description=&amp;tabindex=0&amp;theme=gravity-theme&amp;styles={&quot;inputPrimaryColor&quot;:&quot;#204ce5&quot;}&amp;hash=993eb255808b4cc4e75d6cc1f80f702b' \/>\n            <input type='hidden' class='gform_hidden' name='gform_submission_method' data-js='gform_submission_method_1' value='iframe' \/>\n            <input type='hidden' class='gform_hidden' name='gform_theme' data-js='gform_theme_1' id='gform_theme_1' value='gravity-theme' \/>\n            <input type='hidden' class='gform_hidden' name='gform_style_settings' data-js='gform_style_settings_1' id='gform_style_settings_1' value='{&quot;inputPrimaryColor&quot;:&quot;#204ce5&quot;}' \/>\n            <input type='hidden' class='gform_hidden' name='is_submit_1' value='1' \/>\n            <input type='hidden' class='gform_hidden' name='gform_submit' value='1' \/>\n            \n            <input type='hidden' class='gform_hidden' name='gform_currency' data-currency='HUF' value='x\/ps8OXoF9Hh6iguf\/P0jaM7Md9199orZt0kksGNnxIl\/0NVi6B7Yok5+ssSTAsAa0iNzXmzZ26lzM0Aa\/MRAFn9wMRK\/b\/KhQ5439VPhSklbdE=' \/>\n            <input type='hidden' class='gform_hidden' name='gform_unique_id' value='' \/>\n            <input type='hidden' class='gform_hidden' name='state_1' value='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' \/>\n            <input type='hidden' autocomplete='off' class='gform_hidden' name='gform_target_page_number_1' id='gform_target_page_number_1' value='0' \/>\n            <input type='hidden' autocomplete='off' class='gform_hidden' name='gform_source_page_number_1' id='gform_source_page_number_1' value='1' \/>\n            <input type='hidden' name='gform_field_values' value='' \/>\n            \n        <\/div>\n                        <\/form>\n                        <\/div>\n\t\t                <iframe style='display:none;width:0px;height:0px;' src='about:blank' name='gform_ajax_frame_1' id='gform_ajax_frame_1' title='This iframe contains the logic required to handle Ajax powered Gravity Forms.'><\/iframe>\n\t\t                <script>\ngform.initializeOnLoaded( function() {jQuery('#gform_ajax_frame_1').on('load',function(){var contents = jQuery(this).contents().find('*').html();var is_postback = contents.indexOf('GF_AJAX_POSTBACK') >= 0;if(!is_postback){return;}var form_content = jQuery(this).contents().find('#gform_wrapper_1');var is_confirmation = jQuery(this).contents().find('#gform_confirmation_wrapper_1').length > 0;var is_redirect = contents.indexOf('gformRedirect(){') >= 0;var is_form = form_content.length > 0 && ! is_redirect && ! is_confirmation;var mt = parseInt(jQuery('html').css('margin-top'), 10) + parseInt(jQuery('body').css('margin-top'), 10) + 100;if(is_form){jQuery('#gform_wrapper_1').html(form_content.html());if(form_content.hasClass('gform_validation_error')){jQuery('#gform_wrapper_1').addClass('gform_validation_error');} else {jQuery('#gform_wrapper_1').removeClass('gform_validation_error');}setTimeout( function() { \/* delay the scroll by 50 milliseconds to fix a bug in chrome *\/ jQuery(document).scrollTop(jQuery('#gform_wrapper_1').offset().top - mt); }, 50 );var current_page = jQuery('#gform_source_page_number_1').val();jQuery(document).trigger('gform_page_loaded', [1, current_page]);window['gf_submitting_1'] = false;}else if(!is_redirect){var confirmation_content = jQuery(this).contents().find('.GF_AJAX_POSTBACK').html();if(!confirmation_content){confirmation_content = contents;}jQuery('#gform_wrapper_1').replaceWith(confirmation_content);jQuery(document).scrollTop(jQuery('#gf_1').offset().top - mt);jQuery(document).trigger('gform_confirmation_loaded', [1]);if(window.gform && gform.pagination && gform.pagination.removePageQueryArg){gform.pagination.removePageQueryArg(1);}window['gf_submitting_1'] = false;wp.a11y.speak(jQuery('#gform_confirmation_message_1').text());}else{jQuery('#gform_1').append(contents);if(window['gformRedirect']) {gformRedirect();}}jQuery(document).trigger(\"gform_pre_post_render\", [{ formId: \"1\", currentPage: \"current_page\", abort: function() { this.preventDefault(); } }]);        if (event && event.defaultPrevented) {                return;        }        const gformWrapperDiv = document.getElementById( \"gform_wrapper_1\" );        if ( gformWrapperDiv ) {            const visibilitySpan = document.createElement( \"span\" );            visibilitySpan.id = \"gform_visibility_test_1\";            gformWrapperDiv.insertAdjacentElement( \"afterend\", visibilitySpan );        }        const visibilityTestDiv = document.getElementById( \"gform_visibility_test_1\" );        let postRenderFired = false;        function triggerPostRender() {            if ( postRenderFired ) {                return;            }            postRenderFired = true;            gform.core.triggerPostRenderEvents( 1, current_page );            if ( visibilityTestDiv ) {                visibilityTestDiv.parentNode.removeChild( visibilityTestDiv );            }        }        function debounce( func, wait, immediate ) {            var timeout;            return function() {                var context = this, args = arguments;                var later = function() {                    timeout = null;                    if ( !immediate ) func.apply( context, args );                };                var callNow = immediate && !timeout;                clearTimeout( timeout );                timeout = setTimeout( later, wait );                if ( callNow ) func.apply( context, args );            };        }        const debouncedTriggerPostRender = debounce( function() {            triggerPostRender();        }, 200 );        if ( visibilityTestDiv && visibilityTestDiv.offsetParent === null ) {            const observer = new MutationObserver( ( mutations ) => {                mutations.forEach( ( mutation ) => {                    if ( mutation.type === 'attributes' && visibilityTestDiv.offsetParent !== null ) {                        debouncedTriggerPostRender();                        observer.disconnect();                    }                });            });            observer.observe( document.body, {                attributes: true,                childList: false,                subtree: true,                attributeFilter: [ 'style', 'class' ],            });        } else {            triggerPostRender();        }    } );} );\n<\/script>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-17414f42\"><div class=\"gb-container gb-container-17414f42\">\n<figure class=\"gb-block-image gb-block-image-fa32f172\"><img loading=\"lazy\" decoding=\"async\" width=\"130\" height=\"216\" class=\"gb-image gb-image-fa32f172\" src=\"https:\/\/ibsh.hu\/wp-content\/uploads\/2024\/01\/yellow-dot-mesh-vertical.svg\" alt=\"\" title=\"yellow-dot-mesh-vertical\"\/><\/figure>\n\n<figure class=\"gb-block-image gb-block-image-3bf66210\"><img loading=\"lazy\" decoding=\"async\" width=\"735\" height=\"567\" class=\"gb-image gb-image-3bf66210\" src=\"https:\/\/ibsh.hu\/wp-content\/uploads\/2024\/01\/contact-img-2.png\" alt=\"\" title=\"contact-img-2\" srcset=\"https:\/\/ibsh.hu\/wp-content\/uploads\/2024\/01\/contact-img-2.png 735w, https:\/\/ibsh.hu\/wp-content\/uploads\/2024\/01\/contact-img-2-300x231.png 300w, https:\/\/ibsh.hu\/wp-content\/uploads\/2024\/01\/contact-img-2-16x12.png 16w\" sizes=\"auto, (max-width: 735px) 100vw, 735px\" \/><\/figure>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Life Sciences Catalyst Program GINOP Plus-2.1.5-26 Up to HUF 3 Billion in Funding for Healthcare Research and Development Projects \u00dczleti siker minden m\u00e9retben Maximaliz\u00e1lja p\u00e1ly\u00e1zati eredm\u00e9nyeitaz ibsh seg\u00edts\u00e9g\u00e9vel 0 D\u00edjmentes konzult\u00e1ci\u00f3 a t\u00e1mogat\u00e1si lehet\u0151s\u00e9gek kapcs\u00e1n &#8230; <\/p>\n<p class=\"read-more-container\"><a title=\"GINOP Plus-2.1.5-26\" class=\"read-more button\" href=\"https:\/\/ibsh.hu\/en\/ginop-plus-2-1-5-26\/#more-4933\" aria-label=\"Read more about GINOP Plus-2.1.5-26\">Read more<\/a><\/p>","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-4933","page","type-page","status-publish","infinite-scroll-item"],"lang":"en","translations":{"en":4933,"hu":4920},"_links":{"self":[{"href":"https:\/\/ibsh.hu\/en\/wp-json\/wp\/v2\/pages\/4933","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibsh.hu\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ibsh.hu\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ibsh.hu\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ibsh.hu\/en\/wp-json\/wp\/v2\/comments?post=4933"}],"version-history":[{"count":4,"href":"https:\/\/ibsh.hu\/en\/wp-json\/wp\/v2\/pages\/4933\/revisions"}],"predecessor-version":[{"id":4961,"href":"https:\/\/ibsh.hu\/en\/wp-json\/wp\/v2\/pages\/4933\/revisions\/4961"}],"wp:attachment":[{"href":"https:\/\/ibsh.hu\/en\/wp-json\/wp\/v2\/media?parent=4933"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}